The utility of preoperative breast magnetic resonance imaging in invasive breast cancer according to HER2 status.

被引：0
|
作者：
McLaughlin, S. A. [1 ]
Vallow, L. A. [1 ]
Hines, S. L. [1 ]
Tan, W. [1 ]
机构：
[1] Mayo Clin, Jacksonville, FL 32224 USA
来源：
CANCER RESEARCH | 2009年 / 69卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：257S / 257S
页数：1
相关论文
共 50 条
  • [31] Different regulation of growth signal according to HER2 amplification status in primary breast cancer
    Han, S.
    Noh, W. C.
    Kim, J. S.
    Park, C. H.
    Paik, N. S.
    Park, K.
    EJC SUPPLEMENTS, 2007, 5 (04): : 88 - 88
  • [32] Her2 gene status in breast"in situ" and invasive ductal carcinoma
    Cozaru, G. C.
    Mitroi, A. F.
    Aschie, M.
    Brinzan, C. S.
    Poinareanu, I.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 968 - 969
  • [33] Analysis of the pathological response to primary chemotherapy in patients with locally advanced breast cancer (LABC) grouped according to ER, PR and HER2 status.
    Fernandez-Morales, L. A.
    Dalmau, E.
    Martinez, S.
    Arcusa, A.
    Pericay, C.
    Lain, J. M.
    Font, J.
    Tortajada, L.
    Saigi, E.
    Segui-Palmer, M. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 34S - 34S
  • [34] Clinical Impact of Preoperative Magnetic Resonance Imaging in Breast Cancer
    Alabousi, Mostafa
    Patlas, Michael N.
    CANADIAN ASSOCIATION OF RADIOLOGISTS JOURNAL-JOURNAL DE L ASSOCIATION CANADIENNE DES RADIOLOGISTES, 2024, 75 (01): : 15 - 16
  • [35] Preoperative Breast Magnetic Resonance Imaging Use by Breast Density and Family History of Breast Cancer
    Henderson, Louise M.
    Hubbard, Rebecca A.
    Zhu, Weiwei
    Weiss, Julie
    Wernli, Karen J.
    Goodrich, Martha E.
    Kerlikowske, Karla
    DeMartini, Wendy
    Ozanne, Elissa M.
    Onega, Tracy
    JOURNAL OF WOMENS HEALTH, 2018, 27 (08) : 987 - 993
  • [36] Efficacy of HER2 inhibitors in metastatic breast cancer by discordance in HER2 amplification status between primary and metastatic breast cancer
    Van Raemdonck, E.
    Berteloot, P.
    Laenen, A.
    Han, S.
    Van Nieuwenhuysen, E.
    Salihi, R.
    Concin, N.
    Vergote, I.
    Floris, G.
    Wildiers, H.
    Punie, K.
    Neven, P.
    CANCER RESEARCH, 2019, 79 (04)
  • [37] Utility of HER2 Retesting of Histologic Grade 3 Invasive Breast Carcinomas
    Gologorsky, R.
    Axelsson, K.
    Hosfield, E.
    Shim, V.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : S97 - S97
  • [38] Utility of HER2 retesting of histologic grade 3 invasive breast carcinomas
    Gologorsky, Rebecca
    Shim, Veronica
    Axelsson, Karen
    Hosfield, Elizabeth
    Cureton, Elizabeth
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : 443 - 443
  • [39] Efficacy of HER2-targeted therapy for patients with HER2-positive breast cancer according to hormone receptor status.
    Murata, Takeshi
    Takahashi, Maiko
    Hayashida, Tetsu
    Jinno, Hiromitsu
    Kitagawa, Yuko
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (26)
  • [40] HER2 status in breast cancer -: an example of pharmacogenetic testing
    Kroese, Mark
    Zimmern, Ron L.
    Pinder, Sarah E.
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2007, 100 (07) : 326 - 329
12345